Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Conduit C, Inderjeeth AJ, Allen R, Martin AJ, Parulekar W, Mulroe E, McJannett M, Zielinski RR, Thomson A, Tan TH, Sandhu SK, Reaume MN, Pook DW, North SA, Marx GM, Joshua A, Horvath L, McDermott R, Chowdhury S, Chi KN, Zhang AY, Stockler MR, Davis ID, Sweeney CJ; ANZUP Cancer Trials Group. Conduit C, et al. Among authors: north sa. Future Oncol. 2025 Jan 17:1-10. doi: 10.1080/14796694.2024.2440277. Online ahead of print. Future Oncol. 2025. PMID: 39819293 Free article.
Having more resilience factors only gets you so far in the context of neighborhood disadvantage: understanding differential predictors of internalizing symptoms and body mass index in youth with spina bifida.
Scott SR, Peterson RL, North SJ, Merrick JS, Petranovich CL, Wilson PE, Lantagne A, Simpson TS. Scott SR, et al. Among authors: north sj. J Pediatr Psychol. 2024 Dec 5:jsae102. doi: 10.1093/jpepsy/jsae102. Online ahead of print. J Pediatr Psychol. 2024. PMID: 39657001
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
472 results